Recruiting

Continuous Glucose Monitors

Sponsor:

UCLA

Code:

NCT06254768

Conditions

Pediatric Obesity

Eligibility Criteria

Sex: All

Age: 10 - 21

Healthy Volunteers: Accepted

Interventions

Continuous glucose monitor

Study Details

Brief summary:

To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.

Conditions

Pediatric Obesity

Study ID

NCT06254768

Start date

Jan 17, 2023

Status verified date

Feb, 2024

Completion date

Jun, 2024

Anticipated

Primary completion date

Mar, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 10 - 21

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Age 10-21 years BMI >95th percentile

Exclusion Criteria:

  • Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity
  • Intellectual disability
  • Previous or planned bariatric surgery
  • Hemoglobin A1c >6.5 %
  • Current use of medication that impacts weight

Study Design

Enrollment

30 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Unblinded

They will wear the device and have access to their data- UNBLINDED ARM

experimental: Blinded

They will wear the device but will not have access to their data- BLINDED ARM

Interventions

Continuous glucose monitor

its a device used to measure glucose from interstitial fluids and provides feedback regarding the same every 5 minutes.

Primary outcome measure

  • Feasibility of continuous glucose monitor(CGM) use in children and adolescents with obesity [ Time Frame: 6 weeks ]

Central Contacts and Locations

Central contacts

Sri Nikhita Chimatapu, MD

9177414080schimatapu@mednet.ucla.edu

Locations

Pediatric Endocrinology Division, University of California

Recruiting

Los Angeles, California, United States, 90025

Contacts

Sri Nikhita Chimatapu

917-741-4080schimatapu@mednet.ucla.edu

More Information

Sponsor

University of California, Los Angeles

Last update posted

Feb 12, 2024

Last verified

Feb, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of California, Los Angeles on 2024-02-12.